Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ansamitocin P 3
2. Ansamitocin P 3'
3. Ansamitocin P 4
4. Ansamitocins
5. Ansamitomicin P-3
1. Ansamitocin P3
2. 66584-72-3
3. Ansamitomicin P-3
4. Maytansinol Isobutyrate
5. Antibiotic C 15003p3
6. 2'-de(acetylmethylamino)-2'-methylmaytansine
7. Antibiotic C15003p3
8. 7suk7876bg
9. Chebi:29515
10. C15003p3
11. [(1s,2r,3s,5s,6s,16e,18e,20r,21s)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl] 2-methylpropanoate
12. Ansamitocin P 3
13. Maytansine, 2'-de(acetylmethylamino)-2'-methyl-
14. Ansamitosin P3
15. Ansamitosin P 3
16. Ansamitocin-p-3
17. Ansamitosin P-3
18. Nsc-292222
19. Maytansinol-isobutyrate
20. Nsc 292222
21. C 15003p3
22. Unii-7suk7876bg
23. Chembl507305
24. Schembl15706083
25. Ex-a492
26. Zinc4102313
27. Lmpk04000039
28. S2447
29. Cs-1568
30. Ac-35339
31. Hy-15739
32. Q27110111
33. (1s,2r,3s,5s,6s,16e,18e,20r,21s)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1(10,14).0(3,5)]hexacosa-10(26),11,13,16,18-pentaen-6-yl 2-methylpropanoate
| Molecular Weight | 635.1 g/mol |
|---|---|
| Molecular Formula | C32H43ClN2O9 |
| XLogP3 | 3.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 5 |
| Exact Mass | 634.2657086 g/mol |
| Monoisotopic Mass | 634.2657086 g/mol |
| Topological Polar Surface Area | 136 Ų |
| Heavy Atom Count | 44 |
| Formal Charge | 0 |
| Complexity | 1150 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 2 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Tubulin Modulators
Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. (See all compounds classified as Tubulin Modulators.)
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Ansamitocin P3 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ansamitocin P3, including repackagers and relabelers. The FDA regulates Ansamitocin P3 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ansamitocin P3 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ansamitocin P3 supplier is an individual or a company that provides Ansamitocin P3 active pharmaceutical ingredient (API) or Ansamitocin P3 finished formulations upon request. The Ansamitocin P3 suppliers may include Ansamitocin P3 API manufacturers, exporters, distributors and traders.
click here to find a list of Ansamitocin P3 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ansamitocin P3 DMF (Drug Master File) is a document detailing the whole manufacturing process of Ansamitocin P3 active pharmaceutical ingredient (API) in detail. Different forms of Ansamitocin P3 DMFs exist exist since differing nations have different regulations, such as Ansamitocin P3 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ansamitocin P3 DMF submitted to regulatory agencies in the US is known as a USDMF. Ansamitocin P3 USDMF includes data on Ansamitocin P3's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ansamitocin P3 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ansamitocin P3 suppliers with USDMF on PharmaCompass.
Ansamitocin P3 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ansamitocin P3 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ansamitocin P3 GMP manufacturer or Ansamitocin P3 GMP API supplier for your needs.
A Ansamitocin P3 CoA (Certificate of Analysis) is a formal document that attests to Ansamitocin P3's compliance with Ansamitocin P3 specifications and serves as a tool for batch-level quality control.
Ansamitocin P3 CoA mostly includes findings from lab analyses of a specific batch. For each Ansamitocin P3 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ansamitocin P3 may be tested according to a variety of international standards, such as European Pharmacopoeia (Ansamitocin P3 EP), Ansamitocin P3 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ansamitocin P3 USP).
LOOKING FOR A SUPPLIER?
